Calypte's oral HIV test:
This article was originally published in Clinica
The Chinese state Food and Drug Administration (SFDA) has approved Calypte Biomedical's Aware HIV-1/2-OMT rapid oral HIV test. It is the first and only rapid oral fluid HIV diagnostic in the country, the Portland, Oregon-based company claimed. The product will be manufactured and sold by the firm's Chinese subsidiary, Beijing Marr Bio-Pharmaceutical. Calypte said it was "thrilled" with the long-awaited approval - it had originally hoped for a response from the Chinese FDA in mid-2005. HIV incidence in China is rising rapidly, and is expected to reach 15 million by 2010, the firm said. Aware was also approved in India in July 2007 (see Clinica No 1265, p 16).
You may also be interested in...
Topline results with AZD1222 have shown a lower efficacy rate than the Pfizer and Moderna vaccines, but a subgroup receiving a half-dose in their first injection showed a 90% efficacy result.
Krka’s bottom line continues to be stronger than usual, driven by a hike in sales and leaner cost base. Looking to 2021, however, management brought investors back down to earth.
The COVID-19 pandemic has triggered extraordinary levels of collaboration. But competition remains, and many newly created coalitions have yet to be stress tested.